威智醫藥股份有限公司 成立于2006，是一家以技術創新為依托， 研發，生產，銷售 一體的醫藥公司。經歷十幾年的發展，從最初的手性硼烷產品的基礎上不斷延伸產業鏈，已形成硼烷產品，特色原料藥和仿制藥，改良新藥CMC全產業鏈。

威智醫藥專注多步合成，能滿足克級到噸級， 臨床I到臨床III 以及上市生產。

 到目前為止，已經開發和生產超過35種特色原料藥和制劑，主要用于糖尿病、抗真菌、眼科、腫瘤、戒煙、核磁共振造影劑和心血管治療領域。

Viwit Pharmaceuticals Limited (Viwit), founded in 2006, is a fast-growing research-based pharmaceutical company.

Viwit specializes in multi-step synthetic processes in batch sizes from grams to tons to support clinical trials from Phase I to Phase III to post-launch production.  

Viwit aims to shorten the lead time and lower the cost of new drug development.

Till now Viwit has already developed and manufactured more than 35 generic APIs and formulations, mainly in diabetes, anti-fungal, ophthalmic, oncology, smoking cessation, MRI contrast agent and cardiovascular therapeutic areas.